PeptiDream | Sustainability Performance
Engages in drug discovery and development, utilizing proprietary peptide-based technology platforms to identify and develop therapeutic candidates.
2006
Japan
501 - 1,000 employees
Biotechnology
$100M - 500M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#2773
Overall#120
in Japan#46
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$123.8MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
27.1%FY2025
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-5.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.2
20230.3
▼ 1.7%
0.1
▼ 0.9%
63.3
2030Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Available
Human rights policy
Available
Recycling policy
Available
Workplace health & safety policy
Available
44%
Independent Directors
4 out of 9 incl. management
Overall score
65
Environment
78
Social
57
Governance
60
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
